Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients - Wikidata - awgldk - TriplyDB

Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients

Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients

http://www.wikidata.org/entity/Q36126901

about

Polyomaviruses and disease: is there more to know than viremia and viruria?Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.BK virus nephropathy in renal transplant recipients.BK viremia and polyomavirus nephropathy in 352 kidney transplants; risk factors and potential role of mTOR inhibition.Outcome after Desensitization in HLA or ABO-Incompatible Kidney Transplant Recipients: A Single Center Experience.ABO-incompatible living donor kidney transplantation without post-transplant therapeutic plasma exchange.Desensitization Using Bortezomib and High-dose Immunoglobulin Increases Rate of Deceased Donor Kidney Transplantation Early post-transplant complications following ABO-incompatible kidney transplantation.The First Fifty ABO Blood Group Incompatible Kidney Transplantations: The Rotterdam Experience.Incompatible kidney transplantation: a brief overview of the past, present and future.Strategies to overcome the ABO barrier in kidney transplantation.Favorable results in ABO-incompatible renal transplantation without B cell-targeted therapy: Advantages and disadvantages of rituximab pretreatment.Increased risk of infection-associated death with incompatible kidney transplantations.Optimizing Outcomes in Pediatric Renal Transplantation Through the Australian Paired Kidney Exchange Program.The effect of rituximab dose on infectious complications in ABO-incompatible kidney transplantation.Difference in outcomes after antibody-mediated rejection between abo-incompatible and positive cross-match transplantations.ABO desensitization affects cellular immunity and infection control after renal transplantation.Pilot conversion trial from mycophenolic acid to everolimus in ABO-incompatible kidney-transplant recipients with BK viruria and/or viremia.Early identification of renal transplant recipients with high risk of polyomavirus-associated nephropathy.Polyomavirus nephropathy: quantitative urinary polyomavirus-Haufen testing accurately predicts the degree of intrarenal viral disease.The Banff Working Group Classification of Definitive Polyomavirus Nephropathy: Morphologic Definitions and Clinical Correlations.Polyoma virus nephropathy in kidney transplantation.ABO-Incompatible Kidney Transplantation.

P2860

Q28081350-A253F478-1909-409C-B006-272F8842DF61 Q30276550-29BDA2A2-EA64-4A52-A844-4B999A1422AE Q34509585-3E989ECE-2596-4297-BE71-24929CA62EAD Q35006676-F48A2B58-3B7F-49E4-BA81-74AF36D065E3 Q35885244-3E275AF3-80FC-4F4C-A6CE-57002EF0D00C Q36031039-43BAE994-EAC8-4D4D-8B0F-9E956A645DC7 Q36566858-F7D860DA-CA61-4D4B-8690-2CEE32E41530 Q36683142-BE746595-BAEA-4790-8387-93B92E474652 Q37615262-61E2F03F-29D7-4FE6-BF94-F611BD430F3E Q38036246-2BAED2F0-4C07-43B1-BC1C-BB89641CA9B8 Q38577657-BA748725-9CD3-412C-8E22-71025A1A8B51 Q40100407-B9A40000-3E8A-4763-AC76-42DD0D2692BA Q40183610-B3AA1432-4428-4307-9001-5A4F579852AC Q40594003-BA012697-7423-4208-8C04-67ABDCF0C802 Q40670409-614F1FF4-D946-4650-9272-6E5068504C66 Q40815282-F122771E-CC75-4709-B4A4-FD41AE3A1ED5 Q40879749-3ACA765C-EC0D-4852-B91D-A2D0D42864D1 Q40907143-24466D98-C92B-4785-9E3F-DC1C683E61FA Q41271481-CDE7E70A-A397-4C49-AE4C-E04BCD534A33 Q42199120-D2A8DC2A-99B6-480A-83E8-43E2951A7E9C Q47246603-4B96C588-B0FD-4939-8FA4-07C32A4D2C22 Q47556851-92943563-D7DF-436A-BE02-BD795577D1ED Q53656895-6DC04D96-1816-416E-A029-8EE6C0683F04

P2860

Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients

http://www.wikidata.org/entity/Q36126901

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Incidence and outcomes of BK v ...... e kidney transplant recipients

@ast

Incidence and outcomes of BK v ...... e kidney transplant recipients

@en

type

label

Incidence and outcomes of BK v ...... e kidney transplant recipients

@ast

Incidence and outcomes of BK v ...... e kidney transplant recipients

@en

prefLabel

Incidence and outcomes of BK v ...... e kidney transplant recipients

@ast

Incidence and outcomes of BK v ...... e kidney transplant recipients

@en

P1433

Q36126901-874E33DD-EAD0-4EDC-9000-B9EC184E7EED

P1476

Q36126901-0240FC02-DFAD-4AE7-983E-1BCC901B969E

P2093

Q36126901-16DDC07A-8E8F-4CB1-9790-3CA73064B10F

Q36126901-4E562CA2-CD10-4C41-A928-D2E78F16B33C

Q36126901-4F76329C-50BF-467F-92C7-D39B0C255868

Q36126901-52FCA325-B29D-4386-9308-AC7550E0DBA0

Q36126901-5C9E89CD-DF3A-474E-8743-2E9FCEABC6D8

Q36126901-80C279E8-AD75-4122-AD5D-5779678D853C

Q36126901-C0C60C60-1390-43C4-B565-5CE32E1D3F0A

Q36126901-D8E77C0E-B09A-4008-BD98-40479CF80E08

P2860

Q36126901-01506474-9A73-4130-876F-717DA781B82E

Q36126901-0A2EE19F-FFC1-4502-876C-65A434EF2587

Q36126901-0C589224-E22B-40C0-9D95-F1CA11764236

Q36126901-15F9BBD5-18F0-4FDB-ACCC-B3F7D62BC56B

Q36126901-26BBC506-0954-403F-BEB0-EE190F39F970

Q36126901-303FBDDE-E507-4434-87B4-A746071852DE

Q36126901-35B63BCB-FF8C-4EB6-9515-E5E60C36E675

Q36126901-4D95216C-6410-4531-AFCB-45CF1493E6E7

Q36126901-5773FF8B-4042-4314-B27E-8B1B2A1BDCDE

Q36126901-5BC034B0-5187-4159-8B94-60D982D1C351

P304

Q36126901-14A506FE-53D7-46D2-B84A-5A00FAE94A63

P31

Q36126901-14883F4C-6160-48C7-9F33-59DA4592EBBB

P356

Q36126901-97796D1B-1AFA-4D86-8095-7B6652F6C3E0

P433

Q36126901-F4ADB0FE-FF33-42E4-89C4-9BFA2A88DB3A

P478

Q36126901-D4E74AF8-D67E-4261-B06A-3867BC1B6BAC

P50

Q36126901-11BBE160-E5B2-488E-9CA9-0DA240D148C1

Q36126901-1B43A2B8-D1EB-439C-984D-F3017DCC0A87

P577

Q36126901-174CAC42-B82D-4960-AA16-17E31B498DCA

P698

Q36126901-1A6DDCE8-9ADA-4D76-B995-CE5695ADE206

P932

Q36126901-4B026C39-1EC3-4BB8-9ED3-C38634AC2C9D

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Incidence and outcomes of BK v ...... e kidney transplant recipients

@en

P2093

Duvuru Geetha

http://www.w3.org/2001/XMLSchema#string

Edward Kraus

http://www.w3.org/2001/XMLSchema#string

Gaurav Gupta

http://www.w3.org/2001/XMLSchema#string

Karl Womer

http://www.w3.org/2001/XMLSchema#string

Lois Arend

http://www.w3.org/2001/XMLSchema#string

Lorraine Racusen

http://www.w3.org/2001/XMLSchema#string

Robert Montgomery

http://www.w3.org/2001/XMLSchema#string

Serena Bagnasco

http://www.w3.org/2001/XMLSchema#string

P2860

Incompatible live-donor kidney transplantation in the United States: results of a national survey

Polyomavirus BK neutralizing activity in human immunoglobulin preparations.

Accommodation in renal transplantation: unanswered questions.

The Banff 2009 Working Proposal for polyomavirus nephropathy: a critical evaluation of its utility as a determinant of clinical outcome.

C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts.

Presence of urinary Haufen accurately predicts polyomavirus nephropathy.

Risk factors for polyoma virus nephropathy

The decade of polyomavirus BK-associated nephropathy: state of affairs.

ABO incompatible renal transplantation: a paradigm ready for broad implementation.

BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results

P304

1320-1327

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.00770112

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22626962

http://www.w3.org/2001/XMLSchema#string

P932

3408120

http://www.w3.org/2001/XMLSchema#string